ESR1 and breast cancer: Our study is in line with the findings of Jemal et al.[13], showing that U.S. immigrants from East Africa have a low proportion of ER-negative breast tumours, and studies from Nigeria, Ghana, Uganda and from South Africa that found <35% of ER negativity in BC patients from Africa [9–12].